« Back
Home /
Enoxacin (hydrate)

Enoxacin (hydrate)

Manufacturer	MedChem Express
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	500 mg
Item no.	HY-B0268A-500mg
CASRN	84294-96-2
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Enoxacin hydrate (Enoxacin sesquihydrate), a fluoroquinolone, interferes with DNA replication and inhibits bacterial DNA gyrase (IC50=126 µg/ml) and topoisomerase IV (IC50=26.5 µg/ml). Enoxacin hydrate is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin hydrate has potent activities against gram-positive and -negative bacteria. Enoxacin hydrate is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediated microRNA processing[1][2][3][4].
StorageTemperature	4°C (Powder, sealed storage, away from moisture and light)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	347.34
Clinical_Information	Launched
Manufacturers Research_Area	Infection; Cancer
Solubility	1M NaOH : 100 mg/mL (ultrasonic; adjust pH to 11 with NaOH)\|DMSO : 2.78 mg/mL (ultrasonic)\|H2O : < 0.1 mg/mL
Manufacturers Target	Antibiotic; Bacterial; DNA/RNA Synthesis; MicroRNA
Isoform	Quinolone
Pathway	Anti-infection; Cell Cycle/DNA Damage; Epigenetics
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B0268A-500mg-safety-datasheet.pdf